Asset Details
Do you wish to reserve the book?
Anti-tubercular therapy alone for treatment of isolated tubercular retinal vasculitis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Anti-tubercular therapy alone for treatment of isolated tubercular retinal vasculitis
Do you wish to request the book?
Anti-tubercular therapy alone for treatment of isolated tubercular retinal vasculitis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Anti-tubercular therapy alone for treatment of isolated tubercular retinal vasculitis
2022
Overview
PurposeTo compare the time to resolution of perivascular infiltrates in tubercular retinal vasculitis (TRV) between anti-tubercular therapy (ATT) alone, and in combination with systemic corticosteroids.MethodsObservational retrospective cohort study in a tertiary eye centre in eastern India. Patients with TRV who were treated with anti-tubercular therapy (ATT) alone (Group A), or in combination with systemic corticosteroids (Group B) were included in the study. Eyes with additional inflammatory signs (cystoid macular oedema, vitritis ≥2+, optic disc oedema) were excluded. Resolution was defined as complete disappearance of perivascular infiltrates on seven-field fundus photographs. Descriptive statistics were used for demographic data. A linear mixed effects model was applied to adjust for intereye correlations, in patients with bilateral disease. The primary outcome measure was time to resolution of perivascular infiltrates. Secondary outcome measure was need for laser or surgical intervention for management of complications of TRV.ResultsFifty eyes of 39 patients (Group A 21/18 and Group B 29/21) were included. Both groups had similar demographics and severity of vasculitis. All patients had complete resolution of TRV. On adjusting for intereye correlation, the mean difference in time to resolution between the two groups (Group A, 3.24 [95% CI 2.69–3.77] months, and Group B, 4.76 [95% CI 3.52–5.99] months) was not statistically significant (0.96 weeks [−0.52 to 2.45] p = 0.21). Vaso-occlusive complications and healing patterns were similar in both groups.ConclusionsATT alone, may be sufficient for resolution of perivascular infiltrates, in TRV without additional inflammatory signs.
